Literature DB >> 34416820

Long Noncoding RNAs and Human Liver Disease.

Johanna K DiStefano1, Glenn S Gerhard2.   

Abstract

Long noncoding RNAs (lncRNAs) are pervasively transcribed in the genome, exhibit a diverse range of biological functions, and exert effects through a variety of mechanisms. The sheer number of lncRNAs in the human genome has raised important questions about their potential biological significance and roles in human health and disease. Technological and computational advances have enabled functional annotation of a large number of lncRNAs. Though the number of publications related to lncRNAs has escalated in recent years, relatively few have focused on those involved in hepatic physiology and pathology. We provide an overview of evolving lncRNA classification systems and characteristics and highlight important advances in our understanding of the contribution of lncRNAs to liver disease, with a focus on nonalcoholic steatohepatitis, hepatocellular carcinoma, and cholestatic liver disease.

Entities:  

Keywords:  cholestasis; hepatocellular carcinoma; long noncoding RNA; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; pathogenesis

Mesh:

Substances:

Year:  2021        PMID: 34416820      PMCID: PMC9183788          DOI: 10.1146/annurev-pathol-042320-115255

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   32.350


  145 in total

1.  Non-invasive assessment of liver fibrosis: are we ready?

Authors:  Laurent Castera; Massimo Pinzani
Journal:  Lancet       Date:  2010-04-24       Impact factor: 79.321

2.  Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs.

Authors:  John L Rinn; Michael Kertesz; Jordon K Wang; Sharon L Squazzo; Xiao Xu; Samantha A Brugmann; L Henry Goodnough; Jill A Helms; Peggy J Farnham; Eran Segal; Howard Y Chang
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

Review 3.  Illuminating Genomic Dark Matter with RNA Imaging.

Authors:  Arjun Raj; John L Rinn
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-05-01       Impact factor: 10.005

4.  Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

Authors:  Michael R Charlton; Justin M Burns; Rachel A Pedersen; Kymberly D Watt; Julie K Heimbach; Ross A Dierkhising
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

5.  MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.

Authors:  Fujun Yu; Zhongqiu Lu; Jing Cai; Kate Huang; Bicheng Chen; Guojun Li; Peihong Dong; Jianjian Zheng
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.

Authors:  H Xiong; Z Ni; J He; S Jiang; X Li; J He; W Gong; L Zheng; S Chen; B Li; N Zhang; X Lyu; G Huang; B Chen; Y Zhang; F He
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

7.  HOTAIR Epigenetically Modulates PTEN Expression via MicroRNA-29b: A Novel Mechanism in Regulation of Liver Fibrosis.

Authors:  Fujun Yu; Bicheng Chen; Peihong Dong; Jianjian Zheng
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

8.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.

Authors:  Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

9.  Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals.

Authors:  Hidenori Tani; Rena Mizutani; Kazi Abdus Salam; Keiko Tano; Kenichi Ijiri; Ai Wakamatsu; Takao Isogai; Yutaka Suzuki; Nobuyoshi Akimitsu
Journal:  Genome Res       Date:  2012-02-27       Impact factor: 9.043

10.  Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis.

Authors:  Kun Zhang; Zhemin Shi; Mengxia Zhang; Xueyi Dong; Lina Zheng; Guantong Li; Xiaohui Han; Zhi Yao; Tao Han; Wei Hong
Journal:  Cell Death Dis       Date:  2020-02-18       Impact factor: 8.469

View more
  7 in total

1.  Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma.

Authors:  Chi Liu; Jie Gao; Dongjing Yang; Qiwen Yu; Shuijun Zhang
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

2.  Interplay Between GH-regulated, Sex-biased Liver Transcriptome and Hepatic Zonation Revealed by Single-Nucleus RNA Sequencing.

Authors:  Christine N Goldfarb; Kritika Karri; Maxim Pyatkov; David J Waxman
Journal:  Endocrinology       Date:  2022-07-01       Impact factor: 5.051

3.  LINC00152 Drives a Competing Endogenous RNA Network in Human Hepatocellular Carcinoma.

Authors:  Rossella Pellegrino; Mirco Castoldi; Fabio Ticconi; Britta Skawran; Jan Budczies; Fabian Rose; Constantin Schwab; Kai Breuhahn; Ulf P Neumann; Nadine T Gaisa; Sven H Loosen; Tom Luedde; Ivan G Costa; Thomas Longerich
Journal:  Cells       Date:  2022-05-03       Impact factor: 7.666

4.  LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway.

Authors:  Shizan Xu; Yajie Wang; Zhengyang Li; Qian Hua; Miao Jiang; Xiaoming Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

5.  LncRNA 1700020I14Rik promotes AKR1B10 expression and activates Erk pathway to induce hepatocyte damage in alcoholic hepatitis.

Authors:  Yue Wu; Yabin Qi; Yangqiu Bai; Haihui Zhang; Wenliang Zhu; Shengli Zhou; Yanrui Zhang
Journal:  Cell Death Discov       Date:  2022-08-26

Review 6.  Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials.

Authors:  Ahmad Khan; Xiaobo Zhang
Journal:  Bioengineering (Basel)       Date:  2022-08-21

7.  Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets.

Authors:  Fatemeh Kazeminasab; Maryam Baharlooie; Kamran Ghaedi
Journal:  PPAR Res       Date:  2022-09-17       Impact factor: 4.385

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.